Latest Publication In The miRNA Field:

by christoph on September 2, 2009

{ 0 comments }

MicroRNA — A Switch that Determines Cell Behavior and Holds Answers on Disease, Prevention, Treatment

ROCHESTER, Minn. — Thousands of research studies are under way to better understand microRNA — short for micro ribonucleic acid. These tiny genetic strands may play a role in identifying, treating and possibly preventing many diseases, according to the July issue of Mayo Clinic Health Letter.

MicroRNA acts like a switch that changes cell behavior. Different microRNAs are in each tissue of the body. For instance, what makes liver cells unique is, in part, their expression of a particular microRNA that influences which protein is produced. [click to continue…]

{ 0 comments }

MicroRNAs are known to regulate gene expression by interacting with incompletely complementary sequences in a target messenger RNA. But is the converse true: can mRNA expression affect the distribution of miRNAs? A new study1 shows that the 3′ untranslated region of a pseudogene — the tumour suppressor pseudogene PTENP1 — can bind the same miRNAs as the related protein-coding gene, PTEN. This suggests that pseudogenes may have a biological function as ‘decoys’, sequestering miRNAs and thereby affecting their regulation of expressed genes. [click to continue…]

{ 0 comments }

microRNAs and Transplantation

July 21, 2010

from The Online Transplant Center by Kenar D Jhaveri A novel concept has been emerging in the last few years regarding micro RNAs.  It already has reached some human data in transplant patients. What is micro RNA?  These are non coding areas of the RNA that play a critical role in regulation of gene expression. They [...]

Read the full article →

Grant Money Supporting microRNA Research

July 9, 2010

NIH Awards Three Grants Supporting RNAi, microRNA Rx Development -July 08, 2010 Mirna Recommended for $10.3M Texas Grant, Poised to Close $25M Series B – June 24, 2010 NIH Awards More Than $800K in March to Fund Three miRNA-Related Research Projects – March 11, 2010 NIH Awards Over $1M in FY ’10 Funding to miRNA-Related [...]

Read the full article →

microRNA may Control Cocaine Addiction

July 8, 2010

NIH-Supported Finding on Cocaine Addiction: Tiny Molecule, Big Promise NIDA News Release July 7, 2010 Discovery could lead to better ways of predicting drug abuse risk and treating addictions A specific and remarkably small fragment of RNA appears to protect rats against cocaine addiction – and may also protect humans, according to a recent study [...]

Read the full article →

Targeting a Master Regulator of Disease

July 7, 2010

Drugmakers place big bets on the emerging science of microRNA. By Arlene Weintraub San Diego startup Regulus, founded in 2007, has quietly been working on a new way to target RNA for drug development. The company has been studying a subset of RNA molecules called microRNAs, or miRNAs. First discovered in the 1990s, misbehaving miRNAs [...]

Read the full article →

microRNA of the Month – microRNA 219

July 2, 2010

microRNA-219 is highly expressed in the brain and spinal cord and its overexpression is necessary and sufficient to promote oligodendrocyte differentiation.  It functions in part by directly repressing negative regulators of oligodendrocyte differentiation, including transcription factors Sox6 and Hes5.  Additionally, microRNA-219 directly represses the expression of PDGFRalpha, FoxJ3, and ZFP238 proteins, all of which normally [...]

Read the full article →

A Busy Month in the Business of microRNA

June 30, 2010

BUSINESSWIRE – June 29th – Alnylam Obtains Approvals to Initiate Phase I Study with ALN-TTR01 in Patients with TTR-Mediated Amyloidosis (ATTR) June 29th – Mirna Therapeutics Publishes Data Demonstrating In Vivo Proof of Concept for miR-34a microRNA Replacement Therapy in Cancer June 28th – Reimbursement for Rosetta Genomics’ miRview™ mets Test Now Available in Israel [...]

Read the full article →

Featured Publication – miR-661 expression in SNAI1-induced epithelial to mesenchymal transition contributes to breast cancer cell invasion by targeting Nectin-1 and StarD10 messengers

June 24, 2010

Epithelial to mesenchymal transition (EMT) is a key step toward metastasis. MCF7 breast cancer cells conditionally expressing the EMT master regulator SNAI1 were used to identify early expressed microRNAs (miRNAs) and their targets that may contribute to the EMT process. Potential targets of miRNAs were identified by matching lists of in silico predicted targets and [...]

Read the full article →

Largest microRNA Therapeutics Alliance To Date

June 22, 2010

Sanofi-Aventis and Regulus Therapeutics Form Major Strategic Alliance on microRNA Therapeutics Carlsbad, CA., June 22, 2010 – Regulus Therapeutics Inc. and sanofi-aventis (EURONEXT: SAN and NYSE: SNY) announced today that they have entered into a global, strategic alliance to discover, develop, and commercialize microRNA therapeutics.  The alliance represents the largest microRNA partnership formed to date, [...]

Read the full article →